{{Rsnum
|rsid=2285932
|Gene=OAS3
|Chromosome=12
|position=112949145
|Orientation=minus
|GMAF=0.1749
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=OAS3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 50.4 | 38.9
| HCB | 1.5 | 18.4 | 80.1
| JPT | 3.5 | 17.7 | 78.8
| YRI | 1.6 | 0.0 | 98.4
| ASW | 0.0 | 12.3 | 87.7
| CHB | 1.5 | 18.4 | 80.1
| CHD | 0.0 | 13.8 | 86.2
| GIH | 4.0 | 34.7 | 61.4
| LWK | 0.0 | 0.0 | 0.0
| MEX | 5.3 | 26.3 | 68.4
| MKK | 0.0 | 7.7 | 92.3
| TSI | 17.6 | 49.0 | 33.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=21290821
|Title=[Polymorphism in the human 2'-5'-oligoadenylate synthetase genes (OAS), associated with predisposition to severe forms of tick-borne encephalitis, in populations from North Eurasia]
}}

{{PMID|21050126}} Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease.

{{PMID Auto
|PMID=23337612
|Title=Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}